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Background: FFR provides an accurate and reproducible assessment of the functional
severity of coronary stenosis. Whereas stress testing remains the preferred initial modality
for assessment of ischemia, there is limited data comparing it with FFR. We sought to
determine the correlation between cardiac stress testing and coronary fractional flow
reserve (FFR) measurement for assessing the presence, location, and burden of myocardial
ischemia in patients referred for evaluation of coronary artery disease (CAD).
Methods: Over 5-year study period, of the 5420 consecutive coronary angiograms that were
screened, 326 patients had FFR measurements. Of these, 96 patients with FFR measure-
ments who had a preceding stress test (stress echocardiography [SE] or myocardial
perfusion imaging [MPI]) within a year were included.
Results: Of the 96 patients, there were 46 (48%) men and 50 (52%) women with a mean age of
61 ± 10 years. SE was performed in 57 (59.3%) and MPI in 32 (40.7%) of patients. FFR was
0.79 in 54 (56%) patients. Stress testing had low sensitivity (55%) and specificity (47%)
compared to FFR. The concordance between FFR and stress testing was low for both
presence (k¼ 0.03) and location (k¼ 0.05) of the ischemic territory. The number of ischemic
vascular territories was correctly estimated in only 39% of the stress tests. SE was more
likely to overestimate and MPI more likely to underestimate extent of ischemia.
Conclusions: In patients referred for evaluation of CAD, there was poor correlation between
stress testingandFFR.Aprospectivestudycomparing these twomodalitieswithFFR isneeded.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Non-invasive cardiac stress testing is currently the recom-
mended modality for the initial evaluation of patients withve University, 2500 Metro
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ciety of India. All rightssuspected or known coronary artery disease (CAD). The
commonly performed non-invasive stress tests that utilize a
combination of stress (delivered by exercise or a pharmaco-
logic agent) and imaging protocols (using echocardiography or
myocardial perfusion imaging) have a number of limitations.Health Drive, MetroHealth Heart and Vascular Center, Cleveland,
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achieved, quality of the imaging data, as well as inter and
intra-observer variability may influence the test results. In
addition, myocardial perfusion imaging (MPI), which relies
upon the relative uptake of radioactive tracers, can underes-
timate the burden of ischemia, especially in the presence of
multi-vessel disease.
In the evaluation of CAD, the gold standard for diagnostic
tests has historically been the anatomic estimation of coro-
nary stenosis by coronary angiography. More recently, frac-
tional flow reserve (FFR) testing performed in the
catheterization laboratory has allowed for the functional
estimation of coronary stenosis, determined traditionally
with non-invasive stress testing. Numerous trials have un-
equivocally demonstrated the superior cardiovascular out-
comes and cost-effectiveness of FFR-guided percutaneous
coronary intervention.1e4 Hence, there is a need to revaluate
the role of non-invasive cardiac stress testing in the assess-
ment of myocardial ischemia, by comparing it with FFR-
guided estimation of coronary stenosis. There is a striking
lack of literature in this regard.5e9 Therefore, the aim of our
study was to compare non-invasive cardiac stress testing and
FFRe in determining the presence, location, and the burden of
the ischemic vascular territory in patients undergoing evalu-
ation of CAD.2. Methods
This was a retrospective study, conducted at a tertiary-level
academic hospital. A standardized data collection process
was used to obtain all information directly from electronic
patient medical records (Epic Systems Corporation, Verona,
Wisconsin, US) and entered onto a security protected hospital
database. The local institutional review board approved the
study.
2.1. Patient selection
A total of 5420 consecutive coronary angiograms performed
over a five-year period at our institute were screened retro-
spectively using the institutional cardiac catheterization lab-
oratory database. Of these, 326 patients had FFR
measurements, of whom 124 patients who had FFR mea-
surements and a preceding non-invasive stress test within a
year was evaluated. The clinical, laboratory, and stress im-
aging data were obtained by reviewing individual patient
charts. The angiographer's visual assessment of the coronary
anatomy was used to classify the coronary artery lesion as
intermediate (50e70% stenosis) or severe (70% stenosis).
Patientswere considered to have CAD if any of the threemajor
epicardial coronary arteries demonstrated at least 50% ste-
nosis. Multi-vessel CAD was defined as the presence of 50%
stenosis in 2 major epicardial vessels. Non-ST elevation
myocardial infarction (NSTEMI) was defined as electrocar-
diographic ST-segment depression or prominent T-wave
inversion and/or positive biomarkers of necrosis (e.g.,
troponin) in the absence of ST-segment elevation and in an
appropriate clinical setting (chest discomfort or anginal
equivalent).10Patients were excluded if there was, a) an episode of
NSTEMI in the time interval between the stress test and car-
diac catheterization (n¼ 6); or, b) an indeterminate stress test
result (n¼ 2); or c) difficulty in correlation of a vessel with its
corresponding vascular territory either due to a prior coronary
artery bypass grafting (n¼ 15) or due significant disease (50%
stenosis) in the left main coronary artery (n¼ 5). The
remaining 96 patients were included in the analysis.
2.2. Stress echocardiography and myocardial perfusion
imaging
Stress echocardiography (SE) was performed using standard
stress protocols utilizing either treadmill exercise or admin-
istration of dobutamine (atropine supplementation when
necessary). Similarly, stressMPI was performedwith standard
techniques using either treadmill exercise or adenosine
vasodilation. Images were evaluated using the 17-segment
model.11 Stress tests were interpreted by staff cardiologists
and/or radiologists not directly involved in patient care, for
the presence of stress-induced ischemia, its location, and the
number of vascular territories involved.
2.3. Estimation of FFR
FFR measurements were performed on lesions that were of
intermediate severity as determined by the angiographer's
visual assessment of the coronary anatomy. A 6 French
guiding catheter without side-holes was used to engage the
coronary arteries. Heparin or bivalirudin was administered
intravenously for anticoagulation. FFR was performed using
either a 0.014-inch sensor-tipped high-fidelity PressureWire™
(RADIMedical SystemsAB, Uppsala, Sweden) or the 0.014-inch
sensor-tipped Volcano Prime Wire Prestige® Pressure Guide-
wire (VOLCANO Corp, Rancho Cordova, CA). The transducer
was normalized first with the catheter tip to ensure identical
pressure recordings from the pressure wire and coronary
catheter. The pressure sensor was then positioned distal to
the stenosis. The guide catheter was flushed completely of
any contrast material before the measurements and intra-
coronary nitroglycerine was administered prior to induction
of coronary hyperemia. Aortic pressure (phasic andmean) and
coronary pressure distal to the stenosis (phasic and mean)
were recorded at baseline and under maximum coronary hy-
peremia. Coronary hyperemia was induced by adenosine,
administered by intracoronary route (using boluses of
24 mcge96 mcg) or, less frequently, intravenously (at an
infusion rate of 140 mcg/kg/min) at the discretion of the
operator. Hemodynamic data were digitally stored on an
electronic database (Horizon Cardiology™, McKeeson Corpo-
ration) for off-line analysis. FFR was calculated as the ratio of
the mean distal intracoronary pressure to the mean aortic
pressure at peak hyperemia.2
An FFR measurement of 0.79 was considered
abnormal.1,12 Since FFR measurements are not routinely per-
formed in vessels with either severe or no disease, we
imputed FFR values for these vessels for the purposes of the
study. Coronary vessels with total occlusion were assigned an
FFR of 0.50 (n¼ 8 vessels); vessels with >70% angiographic
stenosiswere assigned a value of 0.79 (n¼ 29 vessels); whereas
Table 1 e Baseline characteristics of all patients (n¼ 96).
Variable
Age (years) 61 ± 10
Males 46 (48%)
Race
Caucasian 46 (48%)
AfricaneAmerican 32 (33%)
Body mass index (kg/m2) 31.2 ± 7.2
Cardiovascular risk factors
Hypertension 74 (77%)
Dyslipidemia 64 (67%)
Diabetes 35 (36%)
Smoking 71 (74%)
Family history of coronary artery disease 59 (61%)
History of ischemic heart disease 41 (43%)
Serum creatinine (mg/dL) 0.9 ± 0.3
Mean time interval between cardiac stress
and catheterization (days)
72 ± 93
Stress testing
Pharmacological 52 (54%)
Exercise 44 (46%)
Abnormal stress test 54 (56%)
Angiographic characteristics
LAD 63 (66%)
LCx 29 (30%)
RCA 46 (48%)
Mean fractional flow reserve 0.84 ± 0.01
Fractional flow reserve 0.79 54 (56%)
LAD¼ Left anterior descending artery; LCx¼ Left circumflex artery;
RCA¼ Right coronary artery.
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(n¼ 135 vessels).6
2.4. Evaluating the presence and location of ischemia,
and the ischemic burden
The results of the stress test and FFR were used to determine
which, if any, of the three epicardial vascular territories or
combinations thereof were identified as ischemic. The stress
test was considered to have identified the presence of
ischemia if it demonstrated ‘any ischemia’ i.e. if any one of the
vascular territories were abnormal on the stress test in the
presence of an abnormal FFR in any one of three epicardial
vessels. For evaluating the location of ischemic territories
involved, we noted the exact ischemic territory, if any, or
territories identified by the stress test and the FFR. For esti-
mation of the ischemic burden, the stress test was considered
to have ‘underestimated’ or ‘overestimated’ the ischemic
burden if it identified significantly fewer or greater ischemic
vascular territories respectively, compared to the FFR.
2.5. Statistical analysis
Categorical variables are reported as counts and percentages
and were compared using chi-square statistics. Continuous
variables are presented as means ± SD and were compared
using student's t-test or Wilcoxon nonparametric statistic. p
value of <0.05 was considered to indicate statistical signifi-
cance. Sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) were calculated to assess
the ability of stress testing modality to identify myocardial
ischemia in comparison with an abnormal FFR (i.e. FFR0.79).
The results were analyzed separately on per-patient and per-
vessel basis. Evaluation of per-patient and per-vessel
concordance for ischemia between stress testing and FFR
was done by determining k statistic values: a k statistic of þ1
indicating perfect agreement, 0 indicating agreement as ex-
pected by chance, and 1 indicating complete disagreement.
The mean number of ischemic territories detected by stress
testing and FFR were compared using the ManneWhitney U
test. Data were analyzed using PASW Statistics version 18
(SPSS Inc, Chicago, IL, USA).Table 2 e Diagnostic accuracy of stress test results
compared with fractional flow reserve (FFR)
measurement.
FFR
Abnormal Normal
Stress testing
results
Abnormal 31 23
Normal 23 19
Values in cells represent number of patients.3. Results
Baseline characteristics of the 96 patients included in the
study are presented in Table 1. Of these, 45 patients hadmulti-
vessel disease (Supplementary Table 1).
3.1. Diagnostic accuracy of non-invasive stress testing
When compared with FFR-guided estimation of CAD, non-
invasive stress testing had a sensitivity of 57%, specificity of
45%, positive predictive value of 57% and a negative predictive
value of 45% (Table 2). Similar evaluations were performed for
various sub-groups, i.e. males, females, obese (BMI > 30 kg/
m2), diabetics, and the type of stress test (i.e. SE and MPI) (See
Table 3). In the enriched subset of patients with multi-vessel
disease, stress test results had a higher sensitivity andpositive predictive values along with lower specificity and
negative predictive values compared to the cohort that
included patients with less extensive disease (See Table 3).
3.2. Estimation of the ischemic burden
Of the overall group of 96 patients, in 38 (39%) patients, stress
testing and FFR detected identical ischemic territories (mean
number of territories¼ 0.68 ± 0.81 in both; p¼ 1.00). In 26 pa-
tients (27%), stress testing underestimated the number of
ischemic territories (mean number of territories by stress
testing¼ 0.15 ± 0.37 vs. by FFR¼ 1.35 ± 0.63; p < 0.001). In the
remaining 32 patients (33%), stress testing overestimated
(mean number of territories by stress test¼ 1.72 ± 0.81; by
FFR¼ 0.38 ± 0.66; p < 0.001) the number of ischemic territories
compared to FFR. Estimation of the ischemic burden was
further analyzed based on the type of stress imaging: i.e. MPI
(n¼ 39) and SE (n¼ 57). The proportion of patients with
concordant estimations of the ischemic burden was similar
between the two studies, with MPI correctly identifying the
Table 3 e Diagnostic accuracies of stress testing compared with FFR in the study sub-groups.
Sensitivity Specificity Positive predictive value Negative predictive value
Men (n¼ 46) 63 47 63 47
Women (n¼ 50) 52 44 52 43
Diabetics (n¼ 35) 50 53 59 44
Obese (n¼ 54) 53 45 62 36
Coronary artery disease (n¼ 82) 57 43 66 34
Multi-vessel disease (n¼ 45) 67 22 77 14
Type of stress testing
Stress echocardiography (n¼ 57) 62 39 51 50
Exercise echocardiography (n¼ 37) 63 39 52 50
Dobutamine echocardiography (n¼ 20) 60 40 50 50
Adenosine MPI (n¼ 32) 54 40 67 29
MPI¼myocardial perfusion imaging.
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studies (p¼ 0.30). However, among patients who had discor-
dance (n¼ 21 for MPI and 37 for SE), there was a significant
difference between SE and MPI, with underestimation of the
burden of ischemia more likely with MPI (14 [36%] patients)
than with SE (12 [21%] patients), and overestimation of the
burden of ischemia more likely with SE (25 [44%] patients)
than with MPI (7 [18%]) (p < 0.05 for all comparisons of
discordance).
3.3. Estimation of presence and location of ischemia
The per-patient concordance between stress testing and FFR
for diagnosing the presence of any ischemiawas poor (k¼ 0.03
[95% CI: 0.17 to 0.23]). Similarly, the per-patient concordance
between stress testing and FFR to correctly identify the loca-
tion of the ischemic vascular territory(ies) was also poor
(k¼ 0.05 [95% CI: 0.06 to 0.16]). Even in patients with multi-
vessel disease, the correlation between stress testing and
FFR remained low for diagnosing the presence of any ischemia
(k¼0.09 [95% CI: 0.35 to 0.17]) as well as for correctly
identifying the location of the ischemic vascular territories
(k¼0.02 [95% CI: 0.14 to 0.09]).
3.4. Per-vessel analysis
Per-vessel analysis was done to compare the FFR value of a
vessel with the non-invasive stress test result in the corre-
sponding vascular territory. Of the 288 vessels evaluated, FFR
values were not available for 28 vessels. These were vessels
with intermediate lesions in patients who underwent PCI for
severe lesions in another vessel. Per-vessel analysis was per-
formed on the remaining 260 vessels. Concordant results were
noted in 153 (59%) vessels which had a normal FFR and a
normal stress test in the corresponding territory, and in 20Table 4 e Diagnostic accuracies of stress testing compared wit
Vascular territories (number of vessels) Sensitivity Specifi
LAD (n¼ 89) 37 71
LCx (n¼ 83) 10 89
RCA (n¼ 89) 27 80
Diabetic vessels (n¼ 93) 27 84(8%) vesselswith an abnormal FFR and an abnormal stress test
in the corresponding vascular territory. In contrast, discor-
dant results were noted in 37 (14%) vessels, which had a
normal FFR and an abnormal stress test, and 50 (19%) vessels
with an abnormal FFR and a normal stress test. The concor-
dance between the two forms of testing for correctly identi-
fying ischemia in the vascular territory of the individual vessel
(i.e. per-vessel analysis) was poor (k¼ 0.10 [95% CI: 0.03 to
0.22]). Importantly, the level of agreement remained poor for
the important territory of left anterior descending (LAD) artery
(n¼ 89 vessels) (k¼ 0.07 [95%CI:0.14 to 0.28]). The sensitivity,
specificity, and predictive accuracies for the various sub-
groups of vessels are shown in Table 4.4. Discussion
The main results of our study can be summarized as follows.
In identifying the presence and location of the ischemic
vascular territory, there was poor correlation between non-
invasive stress testing and FFR. The ischemic burden was
correctly estimated in 39% of stress tests, and not significantly
influenced by the type of imaging (i.e. SE orMPI). Among stress
tests, SE was more likely to overestimate and MPI more likely
to underestimate the burden of ischemia.
Poor correlation between stress testing and FFR in diag-
nosing ischemia has been demonstrated in several stud-
ies.5e8,13,14 However, there are limited data comparing the two
methods in their ability to estimate the burden of ischemia. In
addition, there are scant data addressing higher-risk sub-
groups, such as those with multi-vessel or significant LAD
disease. Our study provides useful insights into these previ-
ously unstudied populations. It is worth emphasizing that we
noted a poor correlation between stress testing and FFR in
these high-risk sub-groups. These data suggest that in ah FFR for various vascular territories.
city Positive predictive value Negative predictive value
39 68
11 88
40 68
39 75
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 5 0e5 554significant proportion of patients, non-invasive stress testing
cannot be used in isolation to make confident therapeutic
decisions regarding the functional significance of coronary
lesions.
Notably, there was significant overestimation of ischemia
by stress testing. This was especially true with stress echo-
cardiography. It is plausible that an abnormal stress test may
result from stress-induced physiologic and microvascular
abnormalities despite relatively preserved epicardial flow,
resulting in a correspondingly normal FFR. In this setting,
measurement of the coronary flow reserve, which assays ab-
solute rather than relative changes in coronary blood flow, can
help reconcile the discrepancy. The discrepant results may in
part due to the limitations of FFR in accounting for micro-
vascular disease. Studies indicate that microvascular disease,
which may result in an abnormal stress test, is associated
with worse cardiovascular outcomes.15 An abnormal non-
invasive stress test can be of incremental value in identi-
fying a higher risk cohort despite the coronary angiographic
data.16 However, it remains unknown whether an abnormal
stress test would be of similar incremental prognostic value in
patients with a normal FFR measurement. We also noted an
underestimation of ischemia by stress testing compared to
FFR and this was significantly more common with MPI. This
corroborates the established mechanism of ischemia detec-
tion with MPI, reliant upon the relative uptake of radioactive
tracers.
Discrepancies between non-invasive and invasive
methods of assessment of the functional significance of cor-
onary stenoses may have major prognostic and therapeutic
implications. While it may be intuitive to consider revascu-
larization in patients with an abnormal FFR and despite a
normal non-invasive stress test, this approach is not currently
supported by evidence. However, in patients with stable cor-
onary disease who also have an abnormal FFR (<0.80),
randomization to deferred (medical management) and base-
line revascularization leads to a much higher urgent revas-
cularization rates in the deferral group.12 Also, it is worth
noting that in the absence of FFR-guided assessment of CAD,
vessels with intermediate lesions (i.e. 50e70% stenosis) with a
prior abnormal non-invasive stress test are currently deemed
revascularization appropriate by the ACC/AHA guideline.
However, if FFR measurements were performed and found
normal in this patient group, the potential benefits, risks and
costs of deferred versus index PCI are unclear. Our study was
not designed to address these questions but the findings
highlight these important areas for future trials.5. Limitations
Our study has several limitations. In our study, we imputed
FFR values for severely stenosed, occluded and normal ves-
sels. An FFR estimation of such vessels is often neither clini-
cally prudent nor indicated, either due to therapeutic futility
(occluded vessel), clinically indicated PCI (angiographically
severe disease) or potential for harm from needless instru-
mentation (angiographically normal vessels). Moreover,
similar imputations have been previously reported.6 There-
fore, we believe the assumptionswemade are unlikely to havesignificantly influenced the results of the study and also
reflect real-world clinical practice. Second, we did not use
quantitative angiography to determine the anatomical sig-
nificance of lesions. However, we did not think this was
necessary as our protocol of using visual assessment for
determining the need for FFR assessment has been previously
validated in large trials.1,4 Thirdly, stress test and FFR esti-
mations were not performed simultaneously. While interval
progression of CAD could potentially impact the results, with
the time interval between the two procedures being less than
a year (mean 72 days), disease progression is unlikely to have
played a significant role.17 Moreover, the small numbers of
patients whose disease did progress clinically in the time in-
terval between stress testing and angiography and resulted in
an acute coronary syndrome were excluded from the study.6. Conclusion
In patients undergoing evaluation for CAD, there was poor
correlation between non-invasive stress testing and FFR esti-
mation for the diagnosis and location of ischemia. Compared
with FFR-guided estimation of the extent of ischemia, the MPI
significantly underestimated the burden of ischemia while SE
led to significant overestimation. The increasing utilization of
FFR underscores the need for a large prospective study
comparing FFR with non-invasive stress testing for their
diagnostic and prognostic roles in the assessment of CAD.Appendix A. Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.ihj.2015.02.010.Conflicts of interest
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